Lacerta Therapeutics Competitors and Similar CompaniesClear all
Lacerta Therapeutics's competitors and similar companies include Nouscom, StrideBio and Dyne Therapeutics.
 Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
|  StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Alachua, US HQ Alachua, US | Locations Basel, CH HQ Roma, IT | Locations US HQ | Locations Waltham, US HQ |
Employees | Employees 147% decrease | Employees 522% decrease | Employees 7 | Employees 1451% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 30m (about 6 years ago) | Latest funding round $ 49m (almost 7 years ago) | Latest funding round $ 81.5m (over 3 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 30m | Total funding raised $ 62.6m | Total funding raised $ 97.2m | Total funding raised $ 165m |
For sources of this data, please see the company profile
View Company Profiles
Nouscom
HQ
Basel, CH
Employees
52↓ 2% decrease
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View companyStrideBio
HQ
US
Employees
7
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View companyDyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View company